Assessment of the Modified CHA2DS2VASc Risk Score in Predicting Mortality in Patients Hospitalized With COVID-19

This publication has 13 references indexed in Scilit:

• Development and Validation of a Clinical Risk Score to Predict the Occurrence of Critical Illness in Hospitalized Patients With COVID-19
  JAMA Internal Medicine, 2020
• Risk factors for severity and mortality in adult COVID-19 inpatients in Wuhan
  Journal of Allergy and Clinical Immunology, 2020
• Suspected myocardial injury in patients with COVID-19: Evidence from front-line clinical observation in Wuhan, China
  International Journal of Cardiology, 2020
• Cardiovascular Implications of Fatal Outcomes of Patients With Coronavirus Disease 2019 (COVID-19)
  JAMA Cardiology, 2020
• Association of Cardiac Injury With Mortality in Hospitalized Patients With COVID-19 in Wuhan, China
  JAMA Cardiology, 2020
• Clinical Characteristics of 138 Hospitalized Patients With 2019 Novel Coronavirus–Infected Pneumonia in Wuhan, China
  JAMA, 2020
• Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China
  The Lancet, 2020
• Assessment of the CHA₂DS₂-VASc Score in Predicting Ischemic Stroke, Thromboembolism, and Death in Patients With Heart Failure With and Without Atrial Fibrillation
  JAMA, 2015
• The CHA2DS2VASc score can be used to stratify the prognosis of acute myocardial infarction patients irrespective of presence of atrial fibrillation
  Journal of Cardiology, 2015
• Guidelines for the management of atrial fibrillation
  EP Europace, 2010